Skip to content

Pregabalin Stabilize Cardiovascular Response to Intubation

Research of Pregabalin Stabilize Cardiovascular Response to Laryngoscopy and Tracheal Intubation of Patients Under General Anesthesia

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03456947
Enrollment
90
Registered
2018-03-07
Start date
2017-01-01
Completion date
2017-06-30
Last updated
2018-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effect of Laryngoscopy and Tracheal Intubation

Brief summary

The purpose of the study is to evaluate whether Pregabalin is safe and effective in stabilizing cardiovascular response to laryngoscopy and tracheal intubation of patients under general anesthesia.

Interventions

DRUGPregabalin

the patients receive 150mg or 300mg pregabalin 60 minutes prior to the surgery

Sponsors

Shanghai Zhongshan Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesiologists(ASA) grade I and II scheduled for elective surgery

Exclusion criteria

* patient refusal. * patients with serious chronic kidney, liver, lungs, or cardiovascular diseases. * allergy to any of the study medications. * patients taking sedation or antihypertensive medications. * suspected difficult intubation or intubation time more than 22s. * pregnant or breastfeeding women. * BMI\>30.

Design outcomes

Primary

MeasureTime frameDescription
heart rateheart rate 3 minutes after intubationeffect of 300mg pregabalin, 150mg pregabalin premedication versus control group on the heart rate due to laryngoscopy and tracheal intubation

Secondary

MeasureTime frameDescription
Mean arterial blood pressurebaseline mean arterial blood pressure before drug administration, heart rate before intubation, heart rate after 0 minute, 1minute, 3minutes, 5 minutes, 7minutes, 10minutes after intubation and before skin incisioneffect of 300mg pregabalin, 150mg pregabalin premedication versus control group on the Mean arterial blood pressure due to laryngoscopy and tracheal intubation
systolic blood pressurebaseline systolic blood pressure before drug administration, heart rate before intubation, heart rate after 0 minute, 1minute, 3minutes, 5 minutes, 7minutes, 10minutes after intubation and before skin incisioneffect of 300mg pregabalin, 150mg pregabalin premedication versus control group on the systolic blood pressure due to laryngoscopy and tracheal intubation
diastolic blood pressurebaseline diastolic blood pressure before drug administration, heart rate before intubation, heart rate after 0 minute, 1minute, 3minutes, 5 minutes, 7minutes, 10minutes after intubation and before skin incisioneffect of 300mg pregabalin, 150mg pregabalin premedication versus control group on the diastolic blood pressure due to laryngoscopy and tracheal intubation
Ramsay scorebaseline Ramsay score before drug administration and Ramsay score before intubationRamsay score of 300mg pregabalin, 150mg pregabalin premedication versus
Incidence of all clinical adverse events1hour after surgeryThe occurrence of dizziness, nausea, vomit and allergy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026